• Comparative Evaluation of Pharmacokinetic Properties between Theobromine Suspension and Capsule Form...

• Kim Jae-Woo

• Kim Jung-Ryul, Lim Kyoung-Soo, Kim Bo-Hyung, Shim Jun-Hwa, Yoon Seo-Hyun, Lee Kyung-Hoon, ...

• Journal of Korean Society for Clinical Pharmacology and Therapeutics   2009  Volume.17  No.2 174 ~ 181

• Development of Auto Coding System on the Basis of MedDRA to Analyze Adverse Events for Clinical Tria...

• Jeon Eun-Jeong

• Yim Hyeon-Woo, Song Kil-Yong, Choi In-Young, Lee Young-Jack, Lee Kyoung-Shin

• Journal of Korean Society for Clinical Pharmacology and Therapeutics   2009  Volume.17  No.2 164 ~ 173

• The Revised Declaration of Helsinki and Clinical Research

• Shin Hee-Young

• Journal of Korean Society for Clinical Pharmacology and Therapeutics   2009  Volume.17  No.2 152 ~ 163

• Guidance for the Clinical Trials Evaluation for Osteoarthritis

• Na Han-Sung

• Park Hyun-Joo, Oh Woo-Yong, Han Soon-Young, Choi Ki-Hwan, Wang So-Young, Chung Myeon-Woo

• Journal of Korean Society for Clinical Pharmacology and Therapeutics   2009  Volume.17  No.2 139 ~ 151

• Guidance for the Clinical Trials Evaluation for Hypertension

• Park Hyun-Joo

• Oh Woo-Yong, Na Han-Sung, Han Soon-Young, Choi Ki-Hwan, Wang So-Young, Chung Myeon-Woo

• Journal of Korean Society for Clinical Pharmacology and Therapeutics   2009  Volume.17  No.2 124 ~ 138

• Do we Need "Koreans only" Additional Phase ¥² Trials for Generation of Bridging Data?

• Choe Seong-Choon

• Journal of Korean Society for Clinical Pharmacology and Therapeutics   2009  Volume.17  No.2 119 ~ 123